ESC 365 - Screen-detected atrial fibrillation (AF) and 'micro-AF' after myocardial infarction in patients 70-82 years and risk of cardiovascular events in the OMEMI trial

ESC Professional Premium Access

Screen-detected atrial fibrillation (AF) and 'micro-AF' after myocardial infarction in patients 70-82 years and risk of cardiovascular events in the OMEMI trial

Session: Treatment of atrial fibrillation in patient with coronary artery disease

Topic: Prevalence and Incidence of Atrial Fibrillation

Speaker: Doctor T. Berge (Oslo, NO)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Trygve Berge

Oslo University Hospital Ulleval, Oslo (Norway)

0 follower

4 more presentations in this session

Causes of death in patients with atrial fibrillation and a recent acute coronary syndrome or percutaneous coronary intervention: Insights from the AUGUSTUS trial

Speaker: Professor R. Lopes (Durham, US)

Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General

Speaker: Doctor M. Vitolo (Modena, IT)

Determinants of post-operative atrial fibrillation in 1613 patients undergoing coronary artery bypass grafting in the Statin Therapy In Cardiac Surgery (STICS) trial

Speaker: Doctor R. Wijesurendra (Oxford, GB)

Features of clinical complexity in european patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)

Access the full session

Treatment of atrial fibrillation in patient with coronary artery disease

Speakers: Doctor T. Berge, Professor R. Lopes, Doctor M. Vitolo, Doctor R. Wijesurendra, Doctor M. Proietti

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources